BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Enoxaparin

a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)

998+ PubMed studies analyzed · 609 RCTs · Evidence Score: 76.4

Research Domains

Enoxaparin has been studied across 10 research domains including ❤️ Cardiovascular, 🫁 Respiratory, 🔬 Oncology, 🫘 Kidney, 🔥 Metabolic. The primary research focus is ❤️ Cardiovascular with 74% of studies addressing this area.

Loading evidence profile...

This evidence profile for Enoxaparin is generated deterministically from 998 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.